Literature DB >> 7817805

Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women.

P Szulc1, M Arlot, M C Chapuy, F Duboeuf, P J Meunier, P D Delmas.   

Abstract

We previously showed that circulating undercarboxylated osteocalcin (ucOC) is elevated in elderly women and is a powerful marker of the subsequent risk of hip fracture in elderly institutionalized women (J Clin Invest 1993; 91:1769). To investigate the relationship between bone mass and ucOC, we measured bone mineral density (BMD) of the hip with dual-energy x-ray absorptiometry in 98 elderly institutionalized women, 81.4 +/- 6.0 years old. ucOC was negatively correlated with BMD at all sites (r = -0.26 to -0.38, p < 0.001 to p < 0.0001), even after exclusion of the effect of age by partial correlation (for the femoral neck, r = -0.26, p < 0.01) and after controlling for serum parathyroid hormone. BMD was significantly lower at all sites of measurement in women with elevated ucOC (> 1.65 ng/ml, upper limit of the normal range in young women) than in those with normal ucOC (for the neck, 0.58 +/- 0.13 versus 0.43 +/- 0.13 g/cm2, p < 0.001). Similar results were obtained for ucOC expressed as the fraction of total OC (ucOC%). Multiple regression showed that ucOC has the highest predictive value for BMD when including age and body weight in the equation. In summary, our data indicate that serum ucOC is an independent determinant of BMD of the hip in elderly women. The mechanism by which serum ucOC is related to bone mass is unclear and should be addressed in further studies. However, our data suggest that ucOC level may be an interesting marker in the investigation of bone status in the elderly.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7817805     DOI: 10.1002/jbmr.5650091012

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  39 in total

Review 1.  A four-season molecule: osteocalcin. Updates in its physiological roles.

Authors:  Giovanni Lombardi; Silvia Perego; Livio Luzi; Giuseppe Banfi
Journal:  Endocrine       Date:  2014-08-27       Impact factor: 3.633

2.  Association of serum undercarboxylated osteocalcin with serum estradiol in pre-, peri- and early post-menopausal women.

Authors:  T Yasui; H Uemura; J Tomita; Y Miyatani; M Yamada; M Miura; M Irahara
Journal:  J Endocrinol Invest       Date:  2006-11       Impact factor: 4.256

Review 3.  Drug-induced osteoporosis: beyond glucocorticoids.

Authors:  Karine Briot; Christian Roux
Journal:  Curr Rheumatol Rep       Date:  2008-04       Impact factor: 4.592

4.  Vitamin K and metabolic bone disease.

Authors:  C Vermeer; M H Knapen; L J Schurgers
Journal:  J Clin Pathol       Date:  1998-06       Impact factor: 3.411

5.  No effect of vitamin K1 intake on bone mineral density and fracture risk in perimenopausal women.

Authors:  L Rejnmark; P Vestergaard; P Charles; A P Hermann; C Brot; P Eiken; L Mosekilde
Journal:  Osteoporos Int       Date:  2006-05-09       Impact factor: 4.507

6.  Short-term menatetrenone therapy increases gamma-carboxylation of osteocalcin with a moderate increase of bone turnover in postmenopausal osteoporosis: a randomized prospective study.

Authors:  Masataka Shiraki; Akira Itabashi
Journal:  J Bone Miner Metab       Date:  2009-01-27       Impact factor: 2.626

7.  Level of serum undercarboxylated osteocalcin correlates with bone quality assessed by calcaneal quantitative ultrasound sonometry in young Japanese females.

Authors:  Yoshio Suzuki; Asako Maruyama-Nagao; Keishoku Sakuraba; Sachio Kawai
Journal:  Exp Ther Med       Date:  2017-03-09       Impact factor: 2.447

Review 8.  Integrative physiology: defined novel metabolic roles of osteocalcin.

Authors:  Yu-Sik Kim; Il-Young Paik; Young-Jun Rhie; Sang-Hoon Suh
Journal:  J Korean Med Sci       Date:  2010-06-17       Impact factor: 2.153

9.  Vitamin K2 supplementation does not influence bone loss in early menopausal women: a randomised double-blind placebo-controlled trial.

Authors:  N Emaus; C G Gjesdal; B Almås; M Christensen; A S Grimsgaard; G K R Berntsen; L Salomonsen; V Fønnebø
Journal:  Osteoporos Int       Date:  2009-11-25       Impact factor: 4.507

Review 10.  Bone health. New role for vitamin K?

Authors:  Milly Ryan-Harshman; Walid Aldoori
Journal:  Can Fam Physician       Date:  2004-07       Impact factor: 3.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.